SHZ · 000963.SZ
Huadong Medicine Co., Ltd
CN¥26.61+CN¥0.73 (+2.82%)
Huadong Medicine Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
Loading market information…
SHZ · 002317.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Guangdong Zhongsheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.93% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Guangdong Zhongsheng Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.20 per share, paid annual. The forward yield is 0.84% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Guangdong Zhongsheng Pharmaceutical Co., Ltd.’s next earnings report is currently expected on Oct 30, 2026, with estimated earnings per share of CN¥0.10. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Guangdong Zhongsheng Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥665.47M |
| Q1 2025 | Apr 25, 2025 | CN¥0.10 | CN¥634.26M |
|---|
| Q1 2025 | Apr 25, 2025 | -CN¥0.54 | CN¥559.40M |
|---|
| Q3 2024 | Oct 28, 2024 | CN¥0.08 | CN¥544.00M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥26.61+CN¥0.73 (+2.82%)
Huadong Medicine Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
CN¥16.43+CN¥0.53 (+3.33%)
Zhejiang Huahai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.18% below the high.
CN¥40.69+CN¥0.71 (+1.78%)
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 20.14% below the high.
CN¥19.00+CN¥0.10 (+0.53%)
Chengdu Kanghong Pharmaceutical Group Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 46.57% below the high.
CN¥15.19+CN¥0.60 (+4.11%)
Shandong Buchang Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.76% below the high.
CN¥22.28+CN¥0.20 (+0.91%)
China Resources Jiangzhong Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 19.94% below the high.
CN¥73.80+CN¥0.75 (+1.03%)
Fujian Cosunter Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.47% below the high.
CN¥12.24+CN¥0.14 (+1.16%)
Chongqing Taiji Industry(Group) Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.05% below the high.
